• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Analysis of telomerase activity and telomere length in various liver diseases

Research Project

Project/Area Number 08670557
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Gastroenterology
Research InstitutionChiba University

Principal Investigator

IMAZEKI Fumio  Chiba University, Faculty of Medicine, Lecturer, 医学部, 講師 (40223325)

Co-Investigator(Kenkyū-buntansha) YOKOSUKA Osamu  Chiba University, Faculty of Medicine, Lecturer, 医学部, 講師 (90182691)
Project Period (FY) 1996 – 1997
Project Status Completed (Fiscal Year 1997)
Budget Amount *help
¥2,100,000 (Direct Cost: ¥2,100,000)
Fiscal Year 1997: ¥1,100,000 (Direct Cost: ¥1,100,000)
Fiscal Year 1996: ¥1,000,000 (Direct Cost: ¥1,000,000)
Keywordstelomerase / telomere / hepatocellular carcinoma / TRAP assay / ultrasonography guided liver biopsy / chronic hepatitis / ultrasonegraphy guided liven biopsy / chronis hepatitis / 肝細胞癌 / 慢性肝疾患 / Telomerase活性 / Telomere長
Research Abstract

Telomere, a repititive sequence which resides in the end of chromosomes, shortens during cell division and telomerase activity, which can restore the length of telomere array and immortalize the cell, has been frequently detectable in various malignant tumors. We examined the telomerase activity in 26 hepatocellular carcinomas together with corresponding nontumorous tissues and 20 chronic hepatitis tissues without tumors by TRAP assay. Telomerase activity was found in 22 (85%) of 26 tumor tissues, in 3 (12%) of 26 corresponding nontumorous tissues and in one (5%) of 20 chronic hepatitis tissues. Telomerase activity was detected in tumorous tissues irrespective of the tumor size or the degree of tumor differentiation and we further analyzed quantitatively the telomerase activity in 28 small hepatocellular carcinomas obtained by ultrasonography guided liver biopsy. The mean telomerase activity in 25 tumors, in 3 borderline lesions and in 28 corresponding nontumorous tissues was 133.7(]SY.+-。[)197.3 arbitrary units (AU) , 11.7(]SY.+-。[)11.3 AU and 4.5(]SY.+-。[)7.5 AU,respectively. Nineteen (76%) of 25 tumorous tissues and one (33%) of 3 borderline lesions showed the telomerase activity over 19.5 AU,the mean value plus twice the standard deviation of the activity in nontumorous tissues, in contrast only one (4%) of 28 nontumorous tissues. The telomerase activity was strongly detected in a majority of small hepatocellular carcinoma, while almost no or faint activity was detectable in a majority of nontumorous specimens. The quantitative assay of telomerase activity was considered to be useful in the diagnosis of small hepatocellular carcinoma.

Report

(3 results)
  • 1997 Annual Research Report   Final Research Report Summary
  • 1996 Annual Research Report
  • Research Products

    (4 results)

All Other

All Publications (4 results)

  • [Publications] Hiroshige Kojima et al.: "Telomerase activity and telomere length in hepatocellular carcinoma and chronic liver disease" Gastroenterology. 112. 493-500 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Hiroshige Kojima et al.: "Telomerase activity and telomere length in hepatocellular carcinoma and chronic liver disease." Gastroenterology. 112. 493-500 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Hiroshige Kojima et al: "Telomerase activity and telomere length in hepatocellulan carcinoma and chronic liver disease" Gastroenterology. 112. 493-500 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Kojima H,et al.: "Telomerase activity and telomere length in hepatocellular carcinoma and chronic liver diseases" Gastroenterology. (in press).

    • Related Report
      1996 Annual Research Report

URL: 

Published: 1996-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi